Drug Profile
Research programme: diabetic complications therapeutics and diagnostics - Fuso/HuBit
Alternative Names: Diabetic complications therapeutics and diagnostics research programme - Fuso/HuBitLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Fuso Pharmaceutical Industries; HuBit genomix
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetic complications
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetic-complications in Japan
- 15 Feb 2005 Preclinical trials in Diabetic complications in Japan (unspecified route)